AMR Stakeholder Profile
Global AMR R&D Hub
Focus area/active in: Therapeutics, Human Health, Animal Health, One Health
Company/Organisation type: Government | Development Agency | Public organisation
Initiated by G20, the Global AMR R&D Hub was launched in 2018 to address challenges and improve collaboration in global AMR R&D using a One Health approach. It is a global partnership currently consisting of 17 countries, the European Commission, two philanthropic foundations (Wellcome and Bill & Melinda Gates Foundation) and four observers (FAO, WHO, OIE, OECD). The Global AMR R&D Hub collects and presents information on AMR R&D investments, products, and market interventions. This information is intended for countries, foundations, organisations and initiatives to help set priorities and maximise the impact of resources invested in R&D to mitigate the AMR threat.
The Global AMR R&D Hub will present, for the first time, its Incentives Gallery of the Dynamic Dashboard at the 4th AMR Conference. The Incentives Gallery provides a snapshot of incentives implemented around the world, and across the value-chain, to support and increase the flow of both old and new antibiotics to all who need them.
Get in touch!
Please fill out the form below to get in touch with us.